Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103294807> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2103294807 endingPage "288" @default.
- W2103294807 startingPage "279" @default.
- W2103294807 abstract "Venlafaxine extended release (XR) is the once-daily preparation of venlafaxine, which inhibits the reuptake of serotonin and norepinephrine. At lower doses, venlafaxine XR preferentially blocks the reuptake of serotonin, while at higher doses it blocks the reuptake of serotonin and norepinephrine. Although venlafaxine XR is not approved for pediatric use, it is increasingly being used in the treatment of pediatric anxiety and depressive disorders. While in the past several years there have been numerous randomized, placebo-controlled trials in pediatric generalized and social anxiety and depression, more studies are needed to determine when the utilization of venlafaxine XR in the pediatric population is warranted. Results from completed studies show improvement in generalized and social anxiety symptoms in children and adolescents, but only minimal improvement in depressive symptoms in adolescents, with no improvement in children. Gastrointestinal symptoms are the most commonly reported adverse events. Venlafaxine XR may affect weight, heart rate and blood pressure in the short-term, while its long-term effects are unknown. The most recent and comprehensive meta-analysis reports a 4% risk difference of suicidal ideation/attempt for venlafaxine XR versus placebo in depression trials, and a 1% risk difference for generalized and social anxiety studies. This paper will review available data regarding the safety and efficacy of venlafaxine XR use in the pediatric population, as well as the pharmacokinetics and pharmacodynamics of this medication." @default.
- W2103294807 created "2016-06-24" @default.
- W2103294807 creator A5051630644 @default.
- W2103294807 creator A5083264470 @default.
- W2103294807 date "2008-06-01" @default.
- W2103294807 modified "2023-09-23" @default.
- W2103294807 title "Venlafaxine extended release in pediatric anxiety and depression" @default.
- W2103294807 cites W1520036360 @default.
- W2103294807 cites W1982193109 @default.
- W2103294807 cites W1991056345 @default.
- W2103294807 cites W2016866934 @default.
- W2103294807 cites W2021560190 @default.
- W2103294807 cites W2025763259 @default.
- W2103294807 cites W2050818564 @default.
- W2103294807 cites W2059171296 @default.
- W2103294807 cites W2069970023 @default.
- W2103294807 cites W2074016011 @default.
- W2103294807 cites W2099840408 @default.
- W2103294807 cites W2105938068 @default.
- W2103294807 cites W2123126302 @default.
- W2103294807 cites W2126095527 @default.
- W2103294807 cites W2262431907 @default.
- W2103294807 cites W2330595721 @default.
- W2103294807 cites W2546672217 @default.
- W2103294807 cites W4249944227 @default.
- W2103294807 doi "https://doi.org/10.2217/17455111.2.3.279" @default.
- W2103294807 hasPublicationYear "2008" @default.
- W2103294807 type Work @default.
- W2103294807 sameAs 2103294807 @default.
- W2103294807 citedByCount "1" @default.
- W2103294807 countsByYear W21032948072022 @default.
- W2103294807 crossrefType "journal-article" @default.
- W2103294807 hasAuthorship W2103294807A5051630644 @default.
- W2103294807 hasAuthorship W2103294807A5083264470 @default.
- W2103294807 hasConcept C118552586 @default.
- W2103294807 hasConcept C126322002 @default.
- W2103294807 hasConcept C142724271 @default.
- W2103294807 hasConcept C15744967 @default.
- W2103294807 hasConcept C197934379 @default.
- W2103294807 hasConcept C204787440 @default.
- W2103294807 hasConcept C27081682 @default.
- W2103294807 hasConcept C2776466888 @default.
- W2103294807 hasConcept C2779177272 @default.
- W2103294807 hasConcept C2908647359 @default.
- W2103294807 hasConcept C2909532165 @default.
- W2103294807 hasConcept C558461103 @default.
- W2103294807 hasConcept C71924100 @default.
- W2103294807 hasConcept C99454951 @default.
- W2103294807 hasConceptScore W2103294807C118552586 @default.
- W2103294807 hasConceptScore W2103294807C126322002 @default.
- W2103294807 hasConceptScore W2103294807C142724271 @default.
- W2103294807 hasConceptScore W2103294807C15744967 @default.
- W2103294807 hasConceptScore W2103294807C197934379 @default.
- W2103294807 hasConceptScore W2103294807C204787440 @default.
- W2103294807 hasConceptScore W2103294807C27081682 @default.
- W2103294807 hasConceptScore W2103294807C2776466888 @default.
- W2103294807 hasConceptScore W2103294807C2779177272 @default.
- W2103294807 hasConceptScore W2103294807C2908647359 @default.
- W2103294807 hasConceptScore W2103294807C2909532165 @default.
- W2103294807 hasConceptScore W2103294807C558461103 @default.
- W2103294807 hasConceptScore W2103294807C71924100 @default.
- W2103294807 hasConceptScore W2103294807C99454951 @default.
- W2103294807 hasIssue "3" @default.
- W2103294807 hasLocation W21032948071 @default.
- W2103294807 hasOpenAccess W2103294807 @default.
- W2103294807 hasPrimaryLocation W21032948071 @default.
- W2103294807 hasRelatedWork W1977484631 @default.
- W2103294807 hasRelatedWork W1986043820 @default.
- W2103294807 hasRelatedWork W2014507738 @default.
- W2103294807 hasRelatedWork W2037465712 @default.
- W2103294807 hasRelatedWork W2041966651 @default.
- W2103294807 hasRelatedWork W2066358721 @default.
- W2103294807 hasRelatedWork W2086027404 @default.
- W2103294807 hasRelatedWork W2164706851 @default.
- W2103294807 hasRelatedWork W2413982830 @default.
- W2103294807 hasRelatedWork W4246121501 @default.
- W2103294807 hasVolume "2" @default.
- W2103294807 isParatext "false" @default.
- W2103294807 isRetracted "false" @default.
- W2103294807 magId "2103294807" @default.
- W2103294807 workType "article" @default.